Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the target of a large decline in short interest in August. As of August 31st, there was short interest totaling 238 shares, a decline of 40.5% from the August 15th total of 400 shares. Based on an average daily volume of 2,022 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.1% of the shares of the stock are short sold.
Innovator IBD Breakout Opportunities ETF Stock Down 0.2%
Shares of BOUT stock traded down $0.09 during trading hours on Wednesday, reaching $42.94. 784 shares of the stock traded hands, compared to its average volume of 3,729. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $49.41. The firm has a market capitalization of $42.90 million, a PE ratio of 28.69 and a beta of 1.02. The business has a fifty day moving average price of $45.43 and a 200 day moving average price of $44.44.
Institutional Inflows and Outflows
An institutional investor recently raised its stake in Innovator IBD Breakout Opportunities ETF stock. Comprehensive Wealth Management LLC grew its holdings in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Free Report) by 122.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,403 shares of the company’s stock after buying an additional 12,859 shares during the quarter. Comprehensive Wealth Management LLC owned 6.69% of Innovator IBD Breakout Opportunities ETF worth $850,000 as of its most recent filing with the SEC.
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
Further Reading
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
